| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
305.000 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
305.000 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
305.000 |
Evidence |
|
| CFL2 |
CFL2: Cofilin-2 |
CFL1 |
CFL1, CFL: Cofilin-1 |
305.000 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
304.000 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
301.000 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
301.000 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
301.000 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
300.000 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
299.000 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
299.000 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
JAK1 |
|
299.000 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
299.000 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
299.000 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
299.000 |
Evidence |
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
299.000 |
Evidence |
O
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
JAK1 |
|
299.000 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
299.000 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
299.000 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
299.000 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
299.000 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
299.000 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
299.000 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
JAK1 |
|
299.000 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
299.000 |
Evidence |
|